MX2016013920A - Anticuerpos monoclonales especificos para cry1ca y metodos de deteccion relacionados. - Google Patents

Anticuerpos monoclonales especificos para cry1ca y metodos de deteccion relacionados.

Info

Publication number
MX2016013920A
MX2016013920A MX2016013920A MX2016013920A MX2016013920A MX 2016013920 A MX2016013920 A MX 2016013920A MX 2016013920 A MX2016013920 A MX 2016013920A MX 2016013920 A MX2016013920 A MX 2016013920A MX 2016013920 A MX2016013920 A MX 2016013920A
Authority
MX
Mexico
Prior art keywords
cry1ca
monoclonal antibodies
detection methods
antibodies specific
related detection
Prior art date
Application number
MX2016013920A
Other languages
English (en)
Inventor
Shan Guomin
Hongzheng MA Eric
P Glancy Todd
E Canada Sarah
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of MX2016013920A publication Critical patent/MX2016013920A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/32—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Bacillus (G)
    • G01N2333/325—Bacillus thuringiensis crystal protein (delta-endotoxin)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G01N2430/10—Insecticides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se describen en la presente anticuerpos monoclonales de murina y métodos útiles para determinar y cuantificar la presencia de la endotoxina Cry1Ca delta. Los anticuerpos reivindicados unen específicamente la región de toxinas centrales tomándolas adecuadas para detectar la toxina nativa Cry1Ca de longitud completa así como también la toxina central amino y las formas truncadas del residuo N-terminal 29.
MX2016013920A 2014-04-29 2015-04-23 Anticuerpos monoclonales especificos para cry1ca y metodos de deteccion relacionados. MX2016013920A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461985654P 2014-04-29 2014-04-29
PCT/US2015/027198 WO2015167912A1 (en) 2014-04-29 2015-04-23 Monoclonal antibodies specific for cry1ca and related detection methods

Publications (1)

Publication Number Publication Date
MX2016013920A true MX2016013920A (es) 2017-02-23

Family

ID=54334532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013920A MX2016013920A (es) 2014-04-29 2015-04-23 Anticuerpos monoclonales especificos para cry1ca y metodos de deteccion relacionados.

Country Status (13)

Country Link
US (1) US9738705B2 (es)
EP (1) EP3137489A4 (es)
JP (1) JP2017514815A (es)
KR (1) KR20160146821A (es)
CN (1) CN106459158A (es)
AR (1) AR100229A1 (es)
AU (1) AU2015253560B2 (es)
BR (1) BR102015009619A2 (es)
CA (1) CA2946848A1 (es)
CL (1) CL2016002710A1 (es)
IL (1) IL248458A0 (es)
MX (1) MX2016013920A (es)
WO (1) WO2015167912A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317241B (zh) * 2019-06-12 2022-09-16 南昌大学 抗Cry1Da蛋白的多肽分子及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017534A (en) * 1996-11-20 2000-01-25 Ecogen, Inc. Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity
US7595380B2 (en) * 2005-04-27 2009-09-29 Tripath Imaging, Inc. Monoclonal antibodies and methods for their use in the detection of cervical disease
JP2010520768A (ja) * 2007-03-09 2010-06-17 トライパス イメージング インコーポレイテッド Ｈｅ４モノクローナル抗体およびそれらの使用方法
CN102762096A (zh) * 2009-12-16 2012-10-31 陶氏益农公司 修饰的cry1ca杀虫cry蛋白
US9567602B2 (en) * 2009-12-16 2017-02-14 Dow Agrosciences Llc Combined use of CRY1Ca and CRY1Fa proteins for insect resistance management
EP2576623B1 (en) * 2010-06-04 2015-01-21 Dow AgroSciences LLC Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
DK2616488T3 (en) * 2010-09-15 2015-05-26 Dow Agrosciences Llc Monoclonal antibodies and methods for detecting enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid

Also Published As

Publication number Publication date
AU2015253560B2 (en) 2017-04-13
IL248458A0 (en) 2016-11-30
JP2017514815A (ja) 2017-06-08
AR100229A1 (es) 2016-09-21
WO2015167912A1 (en) 2015-11-05
US20150309027A1 (en) 2015-10-29
AU2015253560A1 (en) 2016-11-17
EP3137489A1 (en) 2017-03-08
CN106459158A (zh) 2017-02-22
BR102015009619A2 (pt) 2015-12-15
KR20160146821A (ko) 2016-12-21
CL2016002710A1 (es) 2017-03-24
EP3137489A4 (en) 2017-09-20
CA2946848A1 (en) 2015-11-05
US9738705B2 (en) 2017-08-22

Similar Documents

Publication Publication Date Title
MX2023001403A (es) Neoantigenos y metodos de su uso.
AR101846A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MX2020001227A (es) Composiciones y metodos para detectar y cuantificar la proteina en la celula hospedera en las lineas de celulas y productos de polipeptidos recombinantes.
PH12016501212A1 (en) Human anti-il-33 neutralizing monoclonal antibody
MX2021011696A (es) Anticuerpos anti-cd3, anticuerpos anti-cd123 y anticuerpos biespecificos que se unen especificamente a cd3 y/o cd123.
MX2020001272A (es) Anticuerpos dirigidos contra interleucina-33 (il-33).
PH12017500489A1 (en) Human-derived anti-dipeptide repeats (dprs) antibody
MX2018012550A (es) Composiciones y metodos para la deteccion de proteinas de celulas huesped.
WO2018119425A3 (en) Anti-lilrb3 antibodies and methods of use thereof
PH12016501579A1 (en) Novel anti-presepsin antibody
IL262680A (en) Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
MX2022007706A (es) Anticuerpos utiles en diagnosis de cancer.
MX2023009584A (es) Anticuerpos monoclonales anti-chinches y metodos de elaboracion y usos de los mismos.
BR112018073660A2 (pt) anticorpos anti-fator ix pádua
NZ731491A (en) Cd83 binding proteins and uses thereof
MX2016013920A (es) Anticuerpos monoclonales especificos para cry1ca y metodos de deteccion relacionados.
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
MX2016012986A (es) Composiciones y metodos para identificar especies de ehrlichia.
EA201892231A1 (ru) Способ очистки белка
MX2018009218A (es) Anticuerpos de cgrp y sus usos.
WO2017053703A3 (en) Composition and methods for assessing sensitivity and specificity of antibody detection reagents
MX2013014008A (es) Anticuerpo que se aglutina a un polipeptido del transportador a1 del casete de aglutinacion a adenosin trifosfato (atp) (abca 1).
MX2014004285A (es) Deteccion temprana de cancer cervicouterino.
IN2014CH00475A (es)